Lu-177-Labeled Macroaggregated Albumin Imaging and Treatment Effect in Patient with Cystic Thyroid Nodule


SAğER M. S. , AYGÜN A. , KARAYEL E. , Pehlivanoglu H., SÖNMEZOĞLU K.

JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, cilt.48, ss.79-80, 2020 (ESCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 48 Konu: 1
  • Basım Tarihi: 2020
  • Doi Numarası: 10.2967/jnmt.119.226340
  • Dergi Adı: JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY
  • Sayfa Sayıları: ss.79-80

Özet

A number of different peptides or antibodies have been labeled with Lu-177 and used for clinical imaging and treatment. To our knowledge, Lu-177 had never before been used to label macroaggregated albumin, and our radiopharmacy laboratory at Istanbul University-Cerrahpasa made a special effort to do so. We present the case of a 43-y-old man whose cystic thyroid nodule was treated with an intranodular injection of Lu-177-macroaggregated albumin and imaged with SPECT/CT.